{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:45Z","timestamp":1747180845867,"version":"3.40.5"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>To identify triggering receptor expressed in myeloid cells-like transcript-1 positive (TLT-1<jats:sup>+<\/jats:sup>) microparticles (MPs) and evaluate if their presence is associated with clinical outcomes and\/or disease severity in acute respiratory distress syndrome (ARDS).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Retrospective cohort study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>ARDS Network clinical trials.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>A total of 564 patients were diagnosed with ARDS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>Using flow cytometry, we demonstrated the presence of TLT-1<jats:sup>+<\/jats:sup> platelet-derived microparticles (PMP) that bind fibrinogen in plasma samples from fresh donors. We retrospectively quantified TLT-1, glycoprotein (Gp) 1b, or \u03b1<jats:sub>IIb<\/jats:sub>\u03b2<jats:sub>IIIa<\/jats:sub> immunopositive microparticles in plasma samples from patients with ARDS enrolled in the ARMA, KARMA, and LARMA (Studies 01 and 03 lower versus higher tidal volume, ketoconazole treatment, and lisofylline treatment Clincial Trials) ARDS Network clinical trials and evaluated the relationship between these measures and clinical outcomes. No associations were found between Gp1b<jats:sup>+<\/jats:sup> MPs and clinical outcomes for any of the cohorts. When stratified by quartile, associations were found for survival, ventilation-free breathing, and thrombocytopenia with \u03b1<jats:sub>IIb<\/jats:sub>\u03b2<jats:sub>IIIa<\/jats:sub>\n                                 <jats:sup>+<\/jats:sup> and TLT-1<jats:sup>+<\/jats:sup> MPs (\u03c7<jats:sup>2<\/jats:sup>\n                                 <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001). Notably, 63 of 64 patients in this study who failed to achieve unassisted breathing had TLT<jats:sup>+<\/jats:sup> PMP in the 75th percentile. In all three cohorts, patients whose TLT<jats:sup>+<\/jats:sup> MP counts were higher than the median had higher Acute Physiology and Chronic Health Evaluation III scores, were more likely to present with thrombocytopenia and were 3.7 times (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001) more likely to die than patients with lower TLT<jats:sup>+<\/jats:sup> PMP after adjusting for other risk factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Although both \u03b1<jats:sub>IIb<\/jats:sub>\u03b2<jats:sub>IIIa<\/jats:sub>\n                                 <jats:sup>+<\/jats:sup> and TLT<jats:sup>+<\/jats:sup> microparticles (\u03b1<jats:sub>IIb<\/jats:sub>\u03b2<jats:sub>IIIa<\/jats:sub>, TLT-1) were associated with mortality, TLT-1<jats:sup>+<\/jats:sup> MPs demonstrated stronger correlations with Acute Physiology and Chronic Health Evaluation III scores, unassisted breathing, and multiple system organ failure. These findings warrant further exploration of the mechanistic role of TLT-1<jats:sup>+<\/jats:sup> PMP in ARDS or acute lung injury progression.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000001108","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T21:33:00Z","timestamp":1719523980000},"page":"e1108","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["High Levels of Triggering Receptor Expressed in Myeloid Cells-Like Transcript-1 Positive, but Not Glycoprotein 1b+, Microparticles Are Associated With Poor Outcomes in Acute Respiratory Distress Syndrome"],"prefix":"10.1097","volume":"6","author":[{"given":"Angelia D.","family":"Gibson","sequence":"first","affiliation":[{"name":"Division of Natural Sciences, Maryville College, Maryville, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaida","family":"Bayr\u00f3n-Marrero","sequence":"additional","affiliation":[{"name":"Biology Department, University of Puerto Rico, San Juan, PR."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Nieves-Lopez","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Puerto Rico Medical Sciences Campus, San Juan, PR."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ger\u00f3nimo","family":"Maldonado-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Center for Academic Research, Universidad del Sagrado Coraz\u00f3n, San Juan, PR."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3458-1822","authenticated-orcid":false,"given":"A. Valance","family":"Washington","sequence":"additional","affiliation":[{"name":"Department of Biology, Oakland University, Rochester, MI."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"key":"R1-20240806","first-page":"2526","article-title":"Acute respiratory distress syndrome: The Berlin definition.","volume":"307","author":"Force","year":"2012","journal-title":"JAMA"},{"key":"R2-20240806","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ccc.2021.05.001","article-title":"The epidemiology of acute respiratory distress syndrome before and after coronavirus disease 2019.","volume":"37","author":"Hendrickson","year":"2021","journal-title":"Crit Care Clin"},{"key":"R3-20240806","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1001\/jama.283.15.1995","article-title":"Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: A randomized controlled trial. The ARDS Network.","volume":"283","year":"2000","journal-title":"JAMA"},{"key":"R4-20240806","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00003246-200201000-00001","article-title":"Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome.","volume":"30","author":"Network","year":"2002","journal-title":"Crit Care Med"},{"key":"R5-20240806","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","article-title":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.","volume":"342","author":"Brower","year":"2000","journal-title":"N Engl J Med"},{"key":"R6-20240806","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/ajrccm.149.3.7509706","article-title":"The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.","volume":"149","author":"Bernard","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"R7-20240806","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1165\/rcmb.2017-0420TR","article-title":"Amicus or adversary revisited: Platelets in acute lung injury and acute respiratory distress syndrome.","volume":"59","author":"Middleton","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R8-20240806","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1778-428X.2006.00013.x","article-title":"Platelet biology? An overview.","volume":"8","author":"Kickler","year":"2006","journal-title":"Transfusion Alternat Transfusion Med"},{"key":"R9-20240806","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1182\/blood-2004-01-0315","article-title":"A TREM family member, TLT-1, is found exclusively in the alpha-granules of megakaryocytes and platelets.","volume":"104","author":"Washington","year":"2004","journal-title":"Blood"},{"key":"R10-20240806","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.4049\/jimmunol.172.10.5838","article-title":"Cutting edge: TREM-like transcript-1, a platelet immunoreceptor tyrosine-based inhibition motif encoding costimulatory immunoreceptor that enhances, rather than inhibits, calcium signaling via SHP-2.","volume":"172","author":"Barrow","year":"2004","journal-title":"J Immunol"},{"key":"R11-20240806","doi-asserted-by":"crossref","first-page":"13396","DOI":"10.1074\/jbc.M600489200","article-title":"The structure of the extracellular domain of triggering receptor expressed on myeloid cells like transcript-1, and evidence for a naturally occurring soluble fragment.","volume":"281","author":"Gattis","year":"2006","journal-title":"J Biol Chem"},{"key":"R12-20240806","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI36175","article-title":"TREM-like transcript-1 protects against inflammation-associated hemorrhage by facilitating platelet aggregation in mice and humans.","volume":"119","author":"Washington","year":"2009","journal-title":"J Clin Invest"},{"key":"R13-20240806","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1076029614547298","article-title":"Levels of soluble TREM-like transcript 1 in patients presenting to the emergency department with chest pain.","volume":"21","author":"Esponda","year":"2015","journal-title":"Clin Appl Thromb Hemost"},{"key":"R14-20240806","doi-asserted-by":"crossref","first-page":"103638","DOI":"10.1016\/j.jprot.2020.103638","article-title":"Defining the TLT-1 interactome from resting and activated human platelets.","volume":"215","author":"Schmoker","year":"2020","journal-title":"J Proteomics"},{"key":"R15-20240806","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/MBC.0b013e3283358116","article-title":"Soluble TLT-1 modulates platelet-endothelial cell interactions and actin polymerization.","volume":"21","author":"Morales","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R16-20240806","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1182\/blood-2018-03-841593","article-title":"Platelet-derived TLT-1 is a prognostic indicator in ALI\/ARDS and prevents tissue damage in the lungs in a mouse model.","volume":"132","author":"Morales-Ortiz","year":"2018","journal-title":"Blood"},{"key":"R17-20240806","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2141.1967.tb08741.x","article-title":"The nature and significance of platelet products in human plasma.","volume":"13","author":"Wolf","year":"1967","journal-title":"Br J Haematol"},{"key":"R18-20240806","first-page":"161","article-title":"Role of platelet microparticles in blood diseases: Future clinical perspectives.","volume":"49","author":"Chen","year":"2019","journal-title":"Ann Clin Lab Sci"},{"key":"R19-20240806","doi-asserted-by":"crossref","first-page":"7171","DOI":"10.1016\/S0021-9258(18)53161-6","article-title":"Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine.","volume":"268","author":"Chang","year":"1993","journal-title":"J Biol Chem"},{"key":"R20-20240806","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/MOH.0000000000000166","article-title":"The diversity of platelet microparticles.","volume":"22","author":"Boilard","year":"2015","journal-title":"Curr Opin Hematol"},{"key":"R21-20240806","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1182\/blood-2008-06-163832","article-title":"Megakaryocyte-derived microparticles: Direct visualization and distinction from platelet-derived microparticles.","volume":"113","author":"Flaumenhaft","year":"2009","journal-title":"Blood"},{"key":"R22-20240806","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/MOH.0b013e32833e77ee","article-title":"Clinical relevance of microparticles from platelets and megakaryocytes.","volume":"17","author":"Italiano","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"R23-20240806","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1040-8428(98)00044-4","article-title":"Platelet microparticles: A wide-angle perspective.","volume":"30","author":"Horstman","year":"1999","journal-title":"Crit Rev Oncol Hematol"},{"key":"R24-20240806","doi-asserted-by":"crossref","first-page":"L915","DOI":"10.1152\/ajplung.00266.2015","article-title":"Platelets in the pathogenesis of acute respiratory distress syndrome.","volume":"309","author":"Yadav","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R25-20240806","doi-asserted-by":"crossref","first-page":"L74","DOI":"10.1152\/ajplung.00429.2015","article-title":"Early coagulation events induce acute lung injury in a rat model of blunt traumatic brain injury.","volume":"311","author":"Yasui","year":"2016","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R26-20240806","doi-asserted-by":"crossref","first-page":"L364","DOI":"10.1152\/ajplung.00354.2011","article-title":"Microparticles and acute lung injury.","volume":"303","author":"McVey","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R27-20240806","doi-asserted-by":"crossref","first-page":"e0246806","DOI":"10.1371\/journal.pone.0246806","article-title":"Circulating microparticles and activated platelets as novel prognostic biomarkers in COVID-19; relation to cancer.","volume":"16","author":"Zahran","year":"2021","journal-title":"PLoS One"},{"key":"R28-20240806","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fcvm.2017.00074","article-title":"Platelet-derived microvesicles in cardiovascular diseases.","volume":"4","author":"Zaldivia","year":"2017","journal-title":"Front Cardiovasc Med"},{"key":"R29-20240806","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/imr.13127","article-title":"Extracellular vesicles in atherothrombosis: From biomarkers and precision medicine to therapeutic targets.","volume":"312","author":"Badimon","year":"2022","journal-title":"Immunol Rev"},{"key":"R30-20240806","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.thromres.2009.09.013","article-title":"Platelet activation and endogenous thrombin potential in pre-eclampsia.","volume":"125","author":"Macey","year":"2010","journal-title":"Thromb Res"},{"key":"R31-20240806","first-page":"1","article-title":"Platelet-derived microparticles and autoimmune diseases.","volume":"24","author":"Li","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R32-20240806","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s12975-019-00777-w","article-title":"Prognostic value of circulating microvesicle subpopulations in ischemic stroke and TIA.","volume":"11","author":"Lundstrom","year":"2020","journal-title":"Transl Stroke Res"},{"key":"R33-20240806","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/TA.0000000000000437","article-title":"Low level of procoagulant platelet microparticles is associated with impaired coagulation and transfusion requirements in trauma patients.","volume":"77","author":"Windelov","year":"2014","journal-title":"J Trauma Acute Care Surg"},{"key":"R34-20240806","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.blre.2014.04.002","article-title":"Platelet microparticles: Detection and assessment of their paradoxical functional roles in disease and regenerative medicine.","volume":"28","author":"Burnouf","year":"2014","journal-title":"Blood Rev"},{"key":"R35-20240806","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1021\/pr0500760","article-title":"The platelet microparticle proteome.","volume":"4","author":"Garcia","year":"2005","journal-title":"J Proteome Res"},{"key":"R36-20240806","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.aca.2013.03.023","article-title":"Proteomic characterization of human platelet-derived microparticles.","volume":"776","author":"Capriotti","year":"2013","journal-title":"Anal Chim Acta"},{"key":"R37-20240806","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1055\/s-0030-1267038","article-title":"The plasma microparticle proteome.","volume":"36","author":"Little","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"R38-20240806","doi-asserted-by":"crossref","first-page":"e46822","DOI":"10.1371\/journal.pone.0046822","article-title":"Cause or effect of arteriogenesis: Compositional alterations of microparticles from CAD patients undergoing external counterpulsation therapy.","volume":"7","author":"Al Kaabi","year":"2012","journal-title":"PLoS One"},{"key":"R39-20240806","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v3.24692","article-title":"Isolation and characterization of platelet-derived extracellular vesicles.","volume":"3","author":"Aatonen","year":"2014","journal-title":"J Extracell Vesicles"},{"key":"R40-20240806","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1160\/TH09-04-243","article-title":"Proteomic and functional characterisation of platelet microparticle size classes.","volume":"102","author":"Dean","year":"2009","journal-title":"Thromb Haemost"},{"key":"R41-20240806","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fphar.2019.00007","article-title":"Platelet-derived microparticles from obese individuals: Characterization of number, size, proteomics, and crosstalk with cancer and endothelial cells.","volume":"10","author":"Grande","year":"2019","journal-title":"Front Pharmacol"},{"key":"R42-20240806","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1373\/clinchem.2005.057414","article-title":"P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction.","volume":"52","author":"van der Zee","year":"2006","journal-title":"Clin Chem"},{"key":"R43-20240806","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0049-3848(96)00144-2","article-title":"Platelet function and platelet-leukocyte adhesion in symptomatic coronary heart disease. Effects of intravenous magnesium.","volume":"83","author":"Gawaz","year":"1996","journal-title":"Thromb Res"},{"key":"R44-20240806","doi-asserted-by":"crossref","first-page":"e20212218","DOI":"10.1084\/jem.20212218","article-title":"Platelet-derived TLT-1 promotes tumor progression by suppressing CD8+ T cells.","volume":"220","author":"Tyagi","year":"2023","journal-title":"J Exp Med"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T22:10:24Z","timestamp":1722982224000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":44,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000001108","relation":{},"ISSN":["2639-8028"],"issn-type":[{"type":"electronic","value":"2639-8028"}],"subject":[],"published":{"date-parts":[[2024,6,27]]}}}